NEW YORK, NY – The newly merged Lupus Research Alliance raised an unprecedented $3 million for lupus research through its 2016 Walk with Us to Cure Lupus program and TCS NYC Marathon team. By year’s end, the national Walk program will reach approximately $33.5 million raised since its inception in 2002. Every penny – 100% – raised goes […] READ MORE
NEW YORK, NY — The Lupus Research Alliance launched a bold initiative, the Lupus Clinical Investigators Network (LuCIN) to accelerate the identification and development of new therapies to treat lupus. Comprised of leading lupus experts at 58 academic research centers throughout North America, LuCIN provides a coordinated framework to test potential new treatments quickly and cost-effectively while upholding the highest […] READ MORE
Crowd-sourcing, Literature Review and Big Data Analysis Identify Promising Lupus Treatments NEW YORK, NY –- New results published in the professional journal Lupus demonstrate the effectiveness of an innovative system developed to identify promising treatments for lupus among existing drugs approved for use in other diseases. Funded by the Lupus Research Alliance and the John and Marcia […] READ MORE
First Promising Phase II Data in Lupus Nephritis NEW YORK, NY — The Lupus Research Alliance congratulates Aurinia Pharmaceuticals on achieving the first positive Phase II study of a greatly needed potential treatment for lupus nephritis. Up to 60% of people with lupus develop lupus nephritis, a devastating complication that can cause kidney failure and […] READ MORE
Alliance for Lupus Research, the Lupus Research Institute and the S.L.E. Lupus Foundation Unite to Form World’s Preeminent Driver of Lupus Research NEW YORK, NY — The Alliance for Lupus Research (ALR), the Lupus Research Institute (LRI), and the S.L.E. Lupus Foundation today announced the merger of the three organizations to form the Lupus Research […] READ MORE